⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VIVK News
Vivakor, Inc. Common Stock
Vivakor Reports 16% Revenue Growth to $104.4 Million in 2025
globenewswire.com
VIVKD
VIVK
Vivakor Announces Uplisting to Nasdaq Capital Market
globenewswire.com
VIVK
Wearables in Pharma & Biotech Market worth $9.97 billion by 2031 | MarketsandMarkets™
prnewswire.com
BDX
ABT
MASI
AAPL
DXCM
MDT
IRTC
BIIB
GEHC
BSX
VIVK
Form 8-K
sec.gov
VIVK
Vivakor Executes Reverse Stock Split to Advance Nasdaq Continued Listing
globenewswire.com
VIVK
Form 8-K
sec.gov
VIVK
Vivakor Receives Nasdaq Panel Approval for Path to Continued Listing, Upon Compliance by April 30, 2026
globenewswire.com
VIVK
Form 8-K
sec.gov
VIVK
Vivakor Enters Forbearance Agreements with Convertible Noteholders, Extending Maturities to 2027
globenewswire.com
VIVK
Vivakor Signs Letter of Intent to Sell its Midstream Business in Oklahoma STACK Play for $36 Million to Olenox Industries
globenewswire.com
OLOX
VIVK